文献速递前列腺癌

未保险及少数族裔前列腺癌男性患者的癌症复发恐惧

Fear of Cancer Recurrence Among Uninsured and Underrepresented Men With Prostate Cancer.
PubMed 文献 · Urology · 2026-01-12

本研究对150名接受根治性治疗的局限性前列腺癌幸存者进行回顾性横断面分析,发现28%存在高癌症复发恐惧(FCR)。高FCR与较差心理健康、较低SF-12心理综合评分及情绪受限相关,且治疗后悔在高FCR组更常见(95.2% vs 28.7%,P<.001)。结论提示FCR由情绪困扰和决策后悔驱动,而非客观临床风险。

要点

  • 低收入的未保险及少数族裔前列腺癌幸存者中,高癌症复发恐惧者占28%。
  • 高FCR与心理健康差、SF-12心理综合评分低及情绪受限强烈相关。
  • 治疗后悔在高FCR组更普遍(95.2% vs 28.7%,P<.001),需关注心理支持与知情决策。

核心结论

  • 近三分之一的未保险、少数族裔前列腺癌幸存者经历高FCR。
  • 高FCR由情绪困扰和决策后悔驱动,而非客观临床风险。

研究设计与样本

  • 回顾性横断面分析,纳入男性健康研究(2001-2007)中150名完成FCR调查的参与者。
  • 研究对象为接受根治性治疗的局限性前列腺癌幸存者,且为低收入的种族和族裔多样化人群。

主要发现

  • 高FCR(评分≤14,较低三分位)报告率为28%。
  • 年龄、种族/族裔、治疗方式、临床T分期、分级、PSA及合并症与FCR无关。
  • 高FCR与较差心理健康、较低SF-12心理综合评分及情绪受限强烈相关。
  • 治疗后悔在高FCR组显著更常见(95.2% vs 28.7%,P<.001)。
  • 身体健康和前列腺特异性生活质量在高FCR与低FCR组间无差异。

关键数值与推荐

  • 高FCR定义为FCR调查评分≤14(较低三分位)。

临床怎么用

  • 对未保险及少数族裔前列腺癌幸存者应常规评估癌症复发恐惧。
  • 针对高FCR患者,需提供心理支持并促进患者知情决策以减少治疗后悔。
  • 生存期照护应关注心理健康和情绪困扰,而非仅依据临床风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the prevalence of fear of cancer recurrence (FCR) and examine demographic, clinical, and psychosocial factors associated with high FCR among low-income, racially and ethnically diverse prostate cancer survivors treated with definitive therapy for localized disease. METHODS: We conducted a retrospective, cross-sectional analysis of 150 participants enrolled in the Men's Health Study (2001-2007) who completed the FCR Survey at baseline. High FCR was defined as a score ≤14 (lower tertile). Demographic, clinical, and patient-reported outcomes were assessed, including health-related quality of life (SF-12v2), prostate-specific quality of life (PCI-SF), symptom distress, spirituality, patient-physician interaction (PEPPI), and treatment regret. RESULTS: High FCR was reported by 28% of participants. Sociodemographic and clinical variables-including age, race/ethnicity, treatment, clinical T stage, grade, PSA, and comorbidities-were not associated with FCR. High FCR correlated strongly with poorer mental health, lower SF-12 mental composite scores, and emotional limitations. Treatment regret was significantly more prevalent among those with high FCR (95.2% vs 28.7%, P<.001). Physical health and prostate-specific quality of life did not differ by FCR level. CONCLUSION: Nearly one-third of uninsured, underrepresented prostate cancer survivors experienced high FCR, driven by emotional distress and decisional regret rather than objective clinical risk, underscoring the need for equitable, patient-centered survivorship care that supports psychological well-being and promoting patient informed decision-making.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Shachar EK, Connor SE, Chen J, et al. Fear of Cancer Recurrence Among Uninsured and Underrepresented Men With Prostate Cancer. Urology. 2026. PMID: 41534543. doi:10.1016/j.urology.2025.12.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。